DRRX - DURECT CORP
1.91
-0.020 -1.047%
Share volume: 2,787,659
Last Updated: 09-10-2025
Pharmaceutical Products/Pharmaceutical Preparations:
3.17%
PREVIOUS CLOSE
CHG
CHG%
$1.93
-0.02
-0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | |
| Report Date | 05-14-2024 | 08-14-2024 | 11-14-2024 | 03-27-2025 | 05-14-2025 | 08-13-2025 | |
| Assets | |||||||
| Total Assets | 36.221 M | 29.854 M | 24.066 M | 18.349 M | 14.360 M | 12.482 M | |
| Current Assets | 26.085 M | 19.950 M | 14.425 M | 13.175 M | 9.412 M | 7.772 M | |
| Inventories | 2.398 M | 2.474 M | 2.376 M | 106.000 K | 85.000 K | 291.000 K | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 2.187 M | 0.000 | 1.290 M | 792.000 K | 297.000 K | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 19.252 M | 15.646 M | 9.086 M | 11.011 M | 7.963 M | 6.502 M | |
| Total Non-current Assets | 150.000 K | 150.000 K | 150.000 K | 150.000 K | 150.000 K | 150.000 K | |
| Property Plant Equipment | 58.000 K | 67.000 K | 52.000 K | 41.000 K | 38.000 K | 29.000 K | |
| Other Assets | 10.078 M | 9.837 M | 9.589 M | 5.133 M | 4.910 M | 4.681 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||
| Total Liabilities and shareholders’ equity | 36.221 M | 29.854 M | 24.066 M | 18.349 M | 14.360 M | 12.482 M | |
| Total liabilities | 27.921 M | 24.817 M | 22.849 M | 9.218 M | 9.009 M | 8.999 M | |
| Total current liabilities | 24.739 M | 21.928 M | 20.207 M | 7.710 M | 7.673 M | 7.893 M | |
| Accounts Payable | 782.000 K | 394.000 K | 498.000 K | 309.000 K | 313.000 K | 393.000 K | |
| Other liabilities | 3.182 M | 2.889 M | 2.642 M | 1.508 M | 1.336 M | 1.106 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 3.182 M | 2.889 M | 2.642 M | 1.508 M | 1.336 M | 1.106 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 8.300 M | 5.037 M | 1.217 M | 9.131 M | 5.351 M | 3.483 M | |
| Common stock | 604.959 M | 605.393 M | 605.851 M | 606.462 M | 606.914 M | 607.311 M | |
| Retained earnings | -596.649 M | -600.349 M | -604.634 M | -597.330 M | -601.562 M | -603.827 M |